Chemical coupling of a monoclonal antisurfactant protein-B antibody to human urokinase for targeting surfactant-incorporating alveolar fibrin

Bioconjugate Chemistry

Volumn 13, Issue 4, 2002, Pages 804-811

  Ruppert, Clemens ^a   Schmidt, Reinhold ^a   Grimminger, Friedrich ^a   Suzuki, Yasuhiro ^b   Seeger, Werner ^a   Lehr, Claus Michael ^c   Günther, Andreas ^a  

^a JUSTUS LIEBIG UNIVERSITY GIESSEN   (Germany)

^b KYOTO UNIVERSITY   (Japan)

^c SAARLAND UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AFFINITY CHROMATOGRAPHY; ASSAYS; CHAINS; CROSSLINKING; ELECTROPHORESIS; GEL PERMEATION CHROMATOGRAPHY; MOLECULES; MONOCLONAL ANTIBODIES; PLATES (STRUCTURAL COMPONENTS); PURIFICATION; SURFACE ACTIVE AGENTS;

CHEMICAL COUPLING; FIBRIN FORMATION; FIBRINOLYTIC ACTIVITY; HYBRID MOLECULES; HYDROPHOBIC SURFACTANT; INTERSTITIAL LUNG DISEASE; MECHANICAL; PLATE ASSAY; PROPERTY; SURFACE ACTIVITIES;

POLYAMIDEIMIDES;

ANTIBODY CONJUGATE; CROSS LINKING REAGENT; FIBRIN; FIBRINOLYTIC AGENT; MONOCLONAL ANTIBODY; PROTEIN PRECURSOR; PROTEOLIPID; SURFACTANT PROTEIN B PROPEPTIDE; UROKINASE;

ANIMAL; ARTICLE; CATTLE; CHEMISTRY; DRUG DELIVERY SYSTEM; DRUG EFFECT; FIBRINOLYSIS; HUMAN; IMMUNOLOGY; LUNG; METABOLISM; PNEUMONIA;

ANIMALS; ANTIBODIES, MONOCLONAL; CATTLE; CROSS-LINKING REAGENTS; DRUG DELIVERY SYSTEMS; FIBRIN; FIBRINOLYSIS; FIBRINOLYTIC AGENTS; HUMANS; IMMUNOCONJUGATES; LUNG; PNEUMONIA; PROTEIN PRECURSORS; PROTEOLIPIDS; URINARY PLASMINOGEN ACTIVATOR;

EID: 0036074638     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc0255081     Document Type: Article

References (46)

1. Acute respiratory distress in adults
2. Structural alterations of lung parenchyma in the adult respiratory distress syndrome
3. Alveolitis and collapse in the pathogenesis of pulmonary fibrosis
4. Abnormalities in pathways of alveolar fibrin turnover among patients with interstitial lung disease
5. Changes in surfactant in bronchoalveolar lavage fluid after hemithorax irradiation in patients with mesothelioma
6. Idiopathic pulmonary fibrosis
7. Tissue factor procoagulant expression by rat alveolar epithelial cells
8. Procoagulant and plasminogen activator activities of bronchoalveolar fluid in patients with pulmonary sarcoidosis
9. Serial abnormalities of fibrin turnover in evolving adult respiratory distress syndrome
10. Procoagulant activity in bronchoalveolar lavage in the adult respiratory distress syndrome. Contribution of tissue factor associated with factor VII
11. Local abnormalities in coagulation and fibrinolytic pathways predispose to alveolar fibrin deposition in the adult respiratory distress syndrome
12. Local activation of the coagulation and fibrinolysis systems in lung disease
13. Procoagulant activities in human alveolar macrophages
14. Enhanced tissue factor pathway activity and fibrin turnover in the alveolar compartment of patients with interstitial lung disease
15. Alveolar fibrin formation due to enhanced procoagulant and depressed fibrinolytic capacities in severe pneumonia - Comparison with the acute respiratory distress syndrome
16. Depressed bronchoalveolar urokinase activity in patients with adult respiratory distress syndrome
17. Surfactant and the adult respiratory distress syndrome
18. Surfactant alteration and replacement in acute respiratory distress syndrome
19. Surfactant alterations in severe pneumonia, acute respiratory distress syndrome, and cardiogenic lung edema
20. Surfactant abnormalities in idiopathic pulmonary fibrosis, hypersensitivity pneumonitis and sarcoidosis
21. Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome
22. Artificial pulmonary surfactant inhibited by proteins
23. Effects of hemoglobin and cell membrane lipids on pulmonary surfactant activity
24. Surface properties and sensitivity to protein-inhibition of a recombinant apoprotein C-based phospholipid mixture in vitro - Comparison to natural surfactant
25. Alteration of surfactant function due to protein leakage: Special interaction with fibrin monomer
26. Lung surfactant phospholipids associate with polymerizing fibrin: Loss of surface activity
27. Surfactant incorporation markedly alters mechanical properties of a fibrin clot
28. Clot-embedded natural surfactant: Kinetics of fibrinolysis and surface activity
29. Conebulization of surfactant and urokinase restores gas exchange in perfused lungs with alveolar fibrin formation
30. The interaction of fibronectin fragments with fibroblastic cells
31. Fibronectin and integrins in cell adhesion and migration
32. Role of fibronectin as a growth factor for fibroblasts
33. Extracellular matrix injury during lung inflammation
34. Fibronectin-cell interactions
35. Adhesive recognition sequences
36. Cleavage of surfactant-incorporating fibrin by different fibrinolytic agents - Kinetics of lysis and rescue of surface activity
37. A monoclonal antibody to the 15, 000 dalton protein associated with porcine pulmonary surfactant
38. Nucleotide and amino acid sequences of pulmonary surfactant protein SP 18 and evidence for cooperation between SP 18 and SP 28-36 in surfactant lipid adsorption
39. ELISA technique for quantification of surfactant protein B (SP-B) in bronchoalveolar lavage fluid
40. Secretion of plasminogen activator by stimulated macrophages
41. Tissue-type plasminogen activator and urokinase: Differences in the reaction pattern with the active-site titrant 4-methylumbelliferyl-p-guanidinobenzoate hydrochloride
42. Characterization of an antibody-urokinase conjugate. A plasminogen activator targeted to fibrin
43. Preparation and characterization of a disulfide-linked bioconjugate of annexin V with the B-chain of urokinase: An improved fibrinolytic agent targeted to phospholipid-containing thrombi
44. Covalent molecular weight approximately 92 000 hybrid plasminogen activator derived from human plasmin amino-terminal and urokinase carboxyl-terminal domains
45. Pathophysiology of neonatal lung injury induced by monoclonal antibody to surfactant protein B
46. Restoration of lung compliance and prevention of lung fibrosis in a rabbit model of bleomycin induced lung fibrosis upon aerosol application of heparin and urokinase